Fraunhofer Institute for Cell Therapy and Immunology IZIREMEDi4ALL, an ambitious EU-funded research initiative, launches to drive forward the repurposing of medicines in Europe
The EU-funded project REMEDi4ALL willl make a major leap forward in drug repurposing, or finding new therapeutic option for existing drugs, in areas where there are high unmet medical needs. The 3 Fraunhofer institutes participating, for Translational Medicine and Pharmacology ITMP, for Cell Therapy and Immunology IZI and for Algorithms and Scientific Computing SCAI, combine expertise in the realization of in-silico and in-vitro driven drug repurposing programs, the design of predictive in vivo models, the execution of clinical trials and algorithm development for the analysis of drug discovery data.
Within the framework of REMEDi4ALL, Fraunhofer IZI will evaluate already known drug candidates, which are considered interesting in this repurpusing project, in the in vivo animal model. The aim is to develop a technology platform that can then be used in the future to evaluate approved drugs, from the identification of new areas of application, through their in vitro and in vivo testing, to clinical trials.
Please click here for the press release of the Fraunhofer ITMP.